NEC Supports Bipartisan Ensuring Patient Access to Critical Breakthrough Products Act
On Friday, November 21, the New England Council sent a letter to the New England House Delegation in support of H.R.5343, the Ensuring Patient Access to Critical Breakthrough Products Act.
This legislation, which was advanced by the House Ways & Means Committee with strong bipartisan support in September, would provide a clear pathway for four years of transitional Medicare coverage of breakthrough devices upon the manufacturer’s application and requires CMS to make a permanent coverage determination by the end of the temporary period. The Council believes that this expedited coverage pathway could encourage more innovative medical devices to come to market and provide quicker access to treatments for Medicare patients.
If you have any questions about this issue or the Council’s Healthcare Committee, please feel free to contact Sean Malone, Director of Federal Affairs, at smalone@newenglandcouncil.com.